학술논문
Treatment with bestatin (the exogenous synthetic inhibitor of metalloproteinases) reduces the activity of metalloproteinase 2 and 12 in the spleen and lung tissues of rats in a model of lipopolysaccharide-induced sepsis
Document Type
Article
Source
In: Biomedicine and Pharmacotherapy . (Biomedicine and Pharmacotherapy, May 2024, 174)
Subject
Language
English
ISSN
19506007
07533322
07533322